FDA ships Form 483 to generic drug giant Dr. Reddy’s due to equipment issues, other observations
The FDA has issued a Form 483 letter to Indian generic drug giant Dr. Reddy’s Laboratories, after the agency found potentially contaminated drugs during an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
